Patent · US Active

Chromatography process for purification of insulin and insulin analogs

US10155799B2 · kind B2 · utility

0Cited by
10References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 16, 2015
Grant dateDec 18, 2018
Priority date
Expiry dateJul 16, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K1/20
  • WIPO fieldChemical engineering
  • WIPO sectorChemistry

Abstract

A process is described for purifying insulin and insulin analogs that comprises use of two or more orthogonal chromatographic purification steps in tandem following enzymatic digestion of the propeptide-insulin precursor to remove specific product impurities, improve process consistency, and increase process redundancy in the purification of the insulin or insulin analog, e.g., insulin lispro.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.